Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Spark Therapeutics (ONCE) IPO Opens Up 96%
-
Spark Therapeutics (ONCE) Prices 7M Common IPO at $23/Share, Above Expected Range
-
Otonomy Announces Closing of Follow-on Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Spark Therapeutics (ONCE) Boosts Expected IPO Price Range
-
Otonomy (OTIC) Reports $75M Follow-on Public Offering
-
Otonomy Announces Launch of Follow-on Public Offering
-
Otonomy Files Registration Statement for Proposed Follow-on Public Offering
-
Alder BioPharmaceuticals (ALDR) Prices 6M Follow-On at $29.50/Share
-
Alder BioPharmaceuticals (ALDR) Commences 4M Common Follow-On
-
Spark Therapeutics (ONCE) Files $86.25M IPO
-
RFMD and TriQuint Semiconductor to Present at Upcoming Investor Conferences
-
Portola Pharma (PTLA) Prices 6.2M Common Offering at $26/Share
-
Portola Announces Pricing of Public Offering of Common Stock
-
OM Asset Management (OMAM) Sees IPO Price of $15 - $17/Share
-
Otonomy (OTIC) IPO Opens Sharply Higher
-
Micron Technology CEO Mark Durcan to Present May 28 at Sanford C. Bernstein Strategic Decisions Conference
-
Windstream President & CEO Jeff Gardner to Speak at Bernstein Strategic Decisions Conference 2014
-
Huntington Ingalls Industries to Present at Sanford C. Bernstein's Strategic Decisions Conference
-
AmTrust Financial Services, Inc. to Present at Sanford C. Bernstein's 30th Annual Strategic Decisions Conference in New York on Thursday, May 29, 2014
-
Alder BioPharmaceuticals (ALDR) IPO Opens Higher after Weak Pricing
-
Sabre Corporation (SABR) IPO Opens Higher
-
Sabre Corp. (SABR) Prices IPO at $16/Share, Below Expected Range
-
Moelis & Company (MC) IPO Opens Solidly Higher
-
Moelis & Company (MC) Prices IPO at $25/Share
-
Alder BioPharmaceuticals (ALDR) Files $115M IPO
-
Peltz Blasts PepsiCo (PEP) Split Rejection in Letter Demanding Change
-
Portola Pharma (PTLA) Prices 6.37M Common Offering at $23.75/Share
-
Portola Pharma (PTLA) Announces $100M Common Stock Offering
-
Foundation Medicine (FMI) IPO Jumps Over 70%
-
Foundation Medicine (FMI) Upsized IPO Prices at $18, Above Expected Range
-
A Sale or an IPO for Nokia Siemens Networks? (NOK)
-
Coty (COTY) IPO Opens Flat
-
Coty (COTY) Prices 57.1M IPO at $17.50/Share
-
BofA's (BAC) Moynihan: We're Largely Done with MSR Sales
-
West Corp (WSTC) Closes 21.3M IPO at $20/Share
-
West Corp (WSTC) Prices 21.3M IPO at $20/Share
-
Amazon's (AMZN) High-Cost Shift into Cloud Will Payoff in the End
-
Does T-Mobile/ PCS Acquisition Make Sprint (S)/ Leap (LEAP) Deal Imminent?
-
Apple (AAPL) Considers Stock Split, Enabling Addition to Dow Jones Industrial Avg - Bernstein
-
European Wireless Carriers Team Up
-
LPL Investment (LPLA) Prices 14.5M Secondary Offering at $34.50/Share
-
Telefonica (TEF) and China Unicom (CHU) = BFFs!
-
AllianceBernstein (AB) Moves Bernstein CEO James Gingrich to COO of AB; Other Changes Made
-
Netflix (NFLX) Will Cost You More than You Think
-
Investment Tech Group (ITG) Announces Several Management Changes
-
Freescale (FSL) IPO Opens at $19
-
Freescale (FSL) IPO to price at $18/share
-
Freescale Semiconductor (FSL) Sees IPO Price of $22 - $24/Share
-
LPL Investment (LPLA) Prices 6.21M Common Secondary Offering at $34.85/Share
-
Bristol-Myers Squibb (BMY) Melanoma Treatment Could Cost $120K

